BioSpace News Archive

Lirum Therapeutics, Inc. announced today the acceptance for presentation of positive data on LX-101, a novel clinical-stage targeted therapy directed to the insulin-like growth factor 1 receptor (“IGF-1R”), at the 2024 European Society for Medical Oncology (“ESMO”) Sarcoma and Rare Cancers Congress being held from March 14-16.

Gynica, a clinical-stage women’s health biotech startup developing a novel Endometriosis treatment, announces today the submission of a first-in-human Phase 1 trial.

Endologix LLC today announced that Matt Thompson, President and CEO, will present at the Life Science Intelligence (LSI) USA ’24 Emerging Medtech Summit. Scheduled for March 20, 2024, at 10:55 am PT.

Intensity Therapeutics, Inc. announces that Lewis H. Bender , Founder, President will participate in a fireside chat with Roth Managing Director and Senior Analyst, Jonathan Aschoff, Ph.D. at the 36th Annual Roth Conference in Orange County, CA on Tuesday, March 19, at 12:30PM PDT.

Calder Biosciences, Inc ., a next-generation vaccine company, has been published in a Nature Communications article (https://www.nature.com/articles/s41467-024-46295-8 ) that debuts and validates the application of Calder’s ‘3D Vaxlock’ platform technology.

Agilent Technologies Inc. announced that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge, UK, has been awarded the 2024 Darlene Solomon Award.

Autonomix Medical, Inc. today announced the safe completion of the first three patient procedures for its proof-of-concept (PoC) human clinical trial evaluating the use of transvascular RF ablation for the treatment of pancreatic cancer pain.

Natera, Inc., a global leader in cell-free DNA testing, commented on the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, which was recently published by the Kidney Disease Improving Global Outcomes organization, a leading medical society in nephrology.

Endeavor BioMedicines today announced the appointment of Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer (CFO).

GeneDx today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.